D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. - Test2 - elhamkhani - TriplyDB

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

http://www.wikidata.org/entity/Q31991337

about

Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part II The role of dopamine for the pathophysiology of schizophrenia.D2 receptor occupancy under recommended and high doses of olanzapine.Striatal dopamine D2 receptor binding of risperidone in schizophrenic patients as assessed by 123I-iodobenzamide SPECT: a comparative study with olanzapine.Dual-isotope SPECT imaging of striatal dopamine: a comparative study between never-treated and haloperidol-treated first-episode schizophrenic patients.Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.

P2860

Q33612521-D5DCD184-7ADF-4681-B801-EB06239132FC Q34658860-D880ACB3-6B22-40F2-9060-61DD4699D732 Q43743736-5266986C-95E3-4C68-AF92-7ABF06E11431 Q44140145-5446D87A-82D8-4457-B4EF-E824C35F861F Q44568973-2EA07FE6-CCD3-4C13-AA1D-80AA6EC1D33A Q45052993-D825646F-29EA-4567-B96C-C373CE6782B4 Q46727005-4666FA19-308E-42A7-9075-4AFEA3AFC2B0

P2860

D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study.

http://www.wikidata.org/entity/Q31991337

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@ast

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@en

type

label

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@ast

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@en

prefLabel

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@ast

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@en

P1433

Q31991337-9A0F563D-0223-4421-9651-607DB3E4679C

P1476

Q31991337-FAD694B2-70E0-4F11-B65E-231DBFEC97EC

P2093

Q31991337-0154FEA2-DDE0-46EA-A2D0-F713FDE258DB

Q31991337-10BFDDA9-F190-4630-8F00-FC714017F8F8

Q31991337-514FD6CB-D594-4CA7-8568-BD65FD836940

Q31991337-6A2BE114-F93C-4D52-84E6-375DC25813D5

Q31991337-84189DA2-910B-4AEC-8BCF-99F60ACD93E2

Q31991337-A0C357C3-FC77-4072-9EF1-4DE349731843

Q31991337-BA52604E-F55D-4CDE-A6EC-9E95FBC659CC

Q31991337-C6F19626-0DE6-4CCC-99C9-6CBFD2FA36CA

Q31991337-C733461D-A419-42AF-89DD-7DBEC26F7E18

Q31991337-D72B5801-68B8-4A4D-A787-65A2BC055691

P2860

Q31991337-11B27901-E589-4C5B-AA43-7A4E6513A5E5

Q31991337-19911296-3572-4462-86B8-87CD2CEF0483

Q31991337-2DF0B2A6-6775-48DB-8B77-461F61421E4F

Q31991337-4A58525B-93D8-48CB-9C9A-DAEC8BCFE8A8

Q31991337-4C1DF745-382D-47C5-82A2-89B8DA63B130

Q31991337-53BFD1E5-57D7-4019-BC30-0F773213C39B

Q31991337-57E7F980-A61F-4F34-8824-473ECB544E9E

Q31991337-5D7E65C3-157E-486E-BCC2-FB24F7FF80BE

Q31991337-652DE0A7-DF8A-4C58-B06F-1441970506AF

Q31991337-6AC35B44-DAA1-4849-BB00-97B70495E379

P304

Q31991337-8466652E-F775-4E62-8DDF-F2EB98423712

P31

Q31991337-E72C0EA7-3E45-49FC-AFDE-42F41064B775

P356

Q31991337-6C355BDF-4976-462C-86EC-CA4BAF51FB21

P407

Q31991337-097A1678-25CD-433D-8BF6-E1A11141DA12

P433

Q31991337-145FA58B-A1A2-4692-BE6F-3E891FF06BA7

P478

Q31991337-16E6FC87-269A-4043-99BA-F7CEB97B6277

P577

Q31991337-284F97C3-1F99-48DC-BA7D-EBCD5A344EA7

P5875

Q31991337-88AF8951-3FC7-483F-85D3-A12D8D6AEE63

P698

Q31991337-0F67680F-E377-489E-BB5C-EA4310173C9A

P356

026988110001400405

P1433

Journal of Psychopharmacology

P1476

D2 receptor occupancy under re ...... 123-iodobenzamide SPECT study.

@en

P2093

B Rossmüller

http://www.w3.org/2001/XMLSchema#string

E M Meisenzahl

http://www.w3.org/2001/XMLSchema#string

G J Schmitt

http://www.w3.org/2001/XMLSchema#string

H J Möller

http://www.w3.org/2001/XMLSchema#string

K Hahn

http://www.w3.org/2001/XMLSchema#string

K Tatsch

http://www.w3.org/2001/XMLSchema#string

S Dresel

http://www.w3.org/2001/XMLSchema#string

T Frodl

http://www.w3.org/2001/XMLSchema#string

T Mager

http://www.w3.org/2001/XMLSchema#string

U W Preuss

http://www.w3.org/2001/XMLSchema#string

P2860

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

A common action of clozapine, haloperidol, and remoxipride on D1- and D2-dopaminergic receptors in the primate cerebral cortex.

Previous treatment as a confounding variable in studies with novel antipsychotics: two cases of high dopamine-2 receptor occupancy with quetiapine.

Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels.

D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects.

High-dose olanzapine for treatment-refractory schizophrenia.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

P304

364-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/026988110001400405

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12133138

http://www.w3.org/2001/XMLSchema#string

P698

11198054

http://www.w3.org/2001/XMLSchema#string